| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arcellx, Inc. (ACLX) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. ACLX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 782.5K | $90.04M | - | |
| CFO | 45.3K | $5.21M | - | |
| Other | 23.7K | $2.73M | - | |
| Dir | 2.7K | $311.4K | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2025 | Patel Kavita55 | Director | Sale+OE | 1,500 | $64.57 | $96,855.00 | -100% | -4.5% | +2.5% | |
| Jan 14, 2025 | Patel Kavita55 | Director | Sale+OE | 1,500 | $65.87 | $98,801.21 | -60.0% | -6.7% | +8.1% | |
| Jan 8, 2025 | Heery Christopher48 | Chief Medical Officer | Sale+OE | 7,783 | $74.69 | $581,315.58 | -12.7% | -25.8% | -11.0% | |
| Jan 8, 2025 | Gilson Michelle61 | Chief Financial Officer | Sale+OE | 18,009 | $75.24 | $1,355,024.32 | -14.1% | -25.8% | -11.0% | |
| Jan 8, 2025 | Elghandour Rami59 | See Remarks | Sale+OE | 30,311 | $74.69 | $2,263,941.87 | -10.9% | -25.8% | -11.0% | |
| Jan 6, 2025 | Gilson Michelle61 | Chief Financial Officer | Sale+OE | 10,604 | $78.40 | $831,378.66 | -14.7% | -24.5% | -17.3% | |
| Jan 6, 2025 | Heery Christopher48 | Chief Medical Officer | Sale+OE | 6,362 | $78.40 | $498,795.85 | -8.6% | -24.5% | -17.3% | |
| Jan 6, 2025 | Heery Christopher48 | Chief Medical Officer | Sale+OE | 6,362 | $78.40 | $498,795.85 | -8.6% | -24.5% | -17.3% | |
| Jan 6, 2025 | Elghandour Rami59 | See Remarks | Sale+OE | 28,633 | $78.40 | $2,244,895.96 | -8.4% | -24.5% | -17.3% | |
| Dec 24, 2024 | Patel Kavita55 | Director | Sale+OE | 1,500 | $76.97 | $115,450.54 | -93.8% | -6.6% | -14.9% |